Resurgence of leprosy in post elimination era

Swapna Subhash Khatu; Nachiket Madhukarrao Palaskar; Garima Laxminarayan Balpande; Nitin Dinkar Chaudhari

doi:10.18203/issn.2455-4529.IntJResDermatol20194182

Authors

Swapna Subhash Khatu Department of Dermatology, OPD no 6, Smt. Kashibai Navale Medical College and General Hospital, Narhe, Pune, Maharashtra, India
Nachiket Madhukarrao Palaskar Department of Dermatology, OPD no 6, Smt. Kashibai Navale Medical College and General Hospital, Narhe, Pune, Maharashtra, India
Garima Laxminarayan Balpande Department of Dermatology, OPD no 6, Smt. Kashibai Navale Medical College and General Hospital, Narhe, Pune, Maharashtra, India
Nitin Dinkar Chaudhari Department of Dermatology, OPD no 6, Smt. Kashibai Navale Medical College and General Hospital, Narhe, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20194182

Keywords:

Leprosy, Post elimination era, Multidrug therapy

Abstract

Background: Leprosy is a slowly progressive mildly infectious disease caused by Mycobacterium leprae primarily affecting skin and peripheral nerves. After introduction of multidrug therapy in the country recorded leprosy case load has come down. In December 2005, India announced elimination of leprosy as public health problem at national level under the NLEP but new cases are still being registered.

Methods: It was a hospital based cross sectional study conducted on over 109 leprosy patients attending a tertiary care hospital in Narhe, Pune during the period from 1^st January 2018 to 31^stDecember 2018. The statistical package for Social Sciences (SPSS) for Windows version (16.0) was used to analyze the data (SPSS Inc., Chicago, IL). Statistical significance was declared at p<0.05 or mentioned otherwise.

Results: Out of 109 patients, 57 were new and 52 were old. Maximum patients belong to age group 40-49 years, 25 patients had type 1 reaction and 18 had type 2 reaction. Out of which 83 were on treatment and 12 are defaulter, 9 were in relapse, 6 patients released from treatment.

Conclusions: In post elimination era of leprosy still new cases have been registered and hence the burden and morbidity of the disease is still high in the community. It strongly suggests that by early detection, increasing the duration of treatment and by increasing the community awareness, utilizing information, education and communication at all levels, we can hope to reduce the burden of disease in the community and to achieve the dream of leprosy free India.

Metrics

Metrics Loading ...

Author Biography

Swapna Subhash Khatu, Department of Dermatology, OPD no 6, Smt. Kashibai Navale Medical College and General Hospital, Narhe, Pune, Maharashtra, India

Department of Deramatlogy

References

Nayak AK, Satheesh R, Shashidhar K. Spectrum of physical deformities in leprosy patients visiting tertiary care center in Manglore. Ann Trop Med Public Health. 2017;10:22-6.

Anjum V, Swarupa MSK and Neeluri R. Disability status of the leprosy patients enrolled in a tertiary health centre in metropolitan city. Indian J Lepr. 2017;89:15-22.

Mohammad W, Malhotra SK and Garg PK. Clinico-radiological correlation of bone changes in leprosy patients with disabilities/deformities. Indian J Lepr. 2016;88:83-95.

Sangita G, Soumik C. Chronicles of Gerhard-Henrik Armauer Hansen’s life and work. Indian J Dermatol. 2015;60(3):219-21.

Nordeen SK. IAL Text book of leprosy. In: Bhushan K, Kar HK, eds Indian Association of Leprologists. 2nd ed. India: Jaypee Brother Publisher; 2015: 28-30,145-150, 357.

Gupta R, Kar HK, Bhardwaj M. Revalidation of various clinical criteria for the classification of leprosy- a clinic-pathological study. Lepr Rev. 2012;83(4):354-62.

Ridely DS. Leprosy aetiobiology of manifestations treatment and control. Calcutta: Leprosy Field Research Unit, Jhalda, West Bengal. In: Chatterjee BR, ed. IAL Text book of leprosy. 2nd ed. India: Jaypee Brother Publisher; 2016: 280-293.

Ridley DS. The R-J classification re-viewed: classification of leprosy-origin and outcome. In: Chatterjee BR, ed. Leprosy- etiobology of manifestations, treatment and control. Calcutta: Leprosy Field Research Unit, Jhalda, West Bengal. IAL Text book of leprosy. 2nd ed. India: Jaypee Brother Publisher; 2015: 295-297.

Alahi MN, Ahasan M, Akhter T. Clinical profile of leprosy in post elimination era in Kishoreganj District. Shaheed Syed Nazrul. Islam Med Col J. 2019;4:1-9.

Murugaiyan R, Sarvanan G, Karthikeyan K. Changing trends of leprosy in post elimination era- a study from an endemic area. Indian J Lepr. 2017;89:23-7.

Asia AJ, Tapre V, Asia AA. Epidemiological profile of disability. In patients with leprosy in a tertiary care centre. Intl Jsc Res. 2015;5(8).

Swarnakumari G, Rao NTV, Ngeswaramma S, Vani T, Rammohan C, Neenavathu RN. A study of clinical profile of leprosy in post leprosy elimination era. IORS J Dent Med Sci. 2015;14(11):04-12.

Nair SP. A clinic-epidemiological study of pediatric leprosy in the urban leprosy center of a tertiary care institute. Indian J Paediatr Dermatol. 2017;18:24-7.

Santaram V, Porichha D. Reaction cases treated at the regional leprosy training and research institute. Indian J Lepr. 2004;76(4):310-20.

Samuel NM, Susie S, Nakami N, Murmu R. MDT of leprosy-practical application in Nepal. Lepr Rev. 1984;55:265-72.

Singh S, Sinha AK, Banerjee BG, Jaswal N. Participation level of the leprosy patients in society. Indian J Lepr. 2009;81:181-7.

Balachandra AS, Hombal A, Rao S, Varna NM. Radiological changes in hands and feet in leprosy patients with deformities. J Clin Diagn Res. 2011;5(4):703-7.

Arora M, Katoch K, Natrajan M, Kamal R, Yadav VS. Changing profile of disease in leprosy patients diagnosed in a tertiary care centre during years 1995-2000. Indian J Lepr. 2008;80:257-65.

Van Brakel WH, Nicholls PG, Das L, Barkataki P, Suneetha SK, Jadhav RS, et al The INFIR cohort study: investigation prediction, detection. Detection and pathogenesis of neuropathy and reaction in leprosy. Method and baseline results of a cohort of multibacillary leprosy patients in North India. Lepr Rev. 2005;76:14-34.